Cancer therapy has advanced with molecularly targeted approaches and immunotherapy, yet chemotherapy remains essential for ...
The Chinese Society of Nuclear Medicine conducted a national nuclear medicine survey in January 2024. The purpose of the survey was to update the data from 2019 and provide a scientific basis for ...
Journal of Nuclear Medicine March 2025, jnumed.124.268943; DOI: https://doi.org/10.2967/jnumed.124.268943 ...
Journal of Nuclear Medicine March 2025, jnumed.124.269357; DOI: https://doi.org/10.2967/jnumed.124.269357 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268586; DOI: https://doi.org/10.2967/jnumed.124.268586 ...
Journal of Nuclear Medicine March 2025, jnumed.124.269005; DOI: https://doi.org/10.2967/jnumed.124.269005 ...
Journal of Nuclear Medicine February 2025, jnumed.124.268496; DOI: https://doi.org/10.2967/jnumed.124.268496 This paper aims to develop and evaluate the potential of ...
Journal of Nuclear Medicine March 2025, jnumed.124.268035; DOI: https://doi.org/10.2967/jnumed.124.268035 You do not have access to the full text of this article, the ...
Journal of Nuclear Medicine March 2025, jnumed.124.268872; DOI: https://doi.org/10.2967/jnumed.124.268872 ...
You do not have access to the full text of this article, the first page of the PDF of this article appears above. This article requires a subscription to view the full text. If you have a subscription ...
Objectives HER3 is a receptor tyrosine kinase that forms heterodimers with HER2 and EGFR and plays an important role in the pro-oncogenic signaling pathways of HER2+ breast cancer. We developed an ...